A multicenter, prospective randomized controlled modified dual platform trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers (TIGERCAMP). International Journal of Tissue Repair, [S. l.], v. 1, n. Suppl 2, 2025. DOI: 10.63676/njbsev63. Disponível em: https://internationaljournaloftissuerepair.com/index.php/ijtr/article/view/53. Acesso em: 4 nov. 2025.